Posted on by — Leave a comment

Lupus Nephritis Market is Expected to Expand at a Healthy Growth Rate by 2032, States DelveInsight | Key Companies – Novartis Pharmaceuticals, Alexion Pharmaceuticals, Eledon Pharmaceuticals

Lupus Nephritis Market is Expected to Expand at a Healthy Growth Rate by 2032, States DelveInsight | Key Companies - Novartis Pharmaceuticals, Alexion Pharmaceuticals, Eledon Pharmaceuticals
DelveInsight’s “Lupus Nephritis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Lupus Nephritis, historical and forecasted epidemiology as well as the Lupus Nephritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

DelveInsight has launched a new report on “Lupus Nephritis Market Insights, Epidemiology, and Market Forecast-2032”. 

DelveInsight’s “Lupus Nephritis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Lupus Nephritis, historical and forecasted epidemiology as well as the Lupus Nephritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. 

Some of the key facts of the Lupus Nephritis Market Report: 

  • As per Hoover & Costenbader (2016), Lupus nephritis (LN) affects approximately 40% of those with systemic lupus erythematous (SLE). While the majority of new SLE cases occur in individuals between 15 to 40 years of age, approximately 15% of cases arise in patients
  • Recent data suggest the prevalence of SLE in the UK is 97 per 100 000, with 86% of observed cases being female. It is thought that the prevalence of LN in SLE patients is between 20-60%. 
  • A retrospective claims database study stated that In Japan, the prevalence of SLE ranges from 3.7 to 37.7 per 100,000. 

Request for Sample Report: https://www.delveinsight.com/sample-request/lupus-nephritis-market?utm

 

Key benefits of the report:

  1. Lupus Nephritis market report covers a descriptive overview and comprehensive insight of the Lupus Nephritis Epidemiology and Lupus Nephritis  market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Lupus Nephritis market report provides insights on the current and emerging therapies.
  3. Lupus Nephritis market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Lupus Nephritis market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Lupus Nephritis market.

 

 Got queries? Click here to know more about the Lupus Nephritis Market Landscape

 

Lupus Nephritis Overview: 

Lupus nephritis (LN) is a common and potentially devastating manifestation of SLE. It is a leading cause of morbidity and mortality in patients with SLE. LN leads to inflammation of small blood vessels which play an important role in filtering waste materials in the kidney. It also involves the inflammation of glomeruli.

Lupus Nephritis occurs when the Lupus Autoantibodies affect the structure of your kidney which is responsible to filter out waste from the body. This effect on the structure of the body causes swelling and can lead to the discharge of blood in Urine, Protein in Urine, Impaired Kidney Function, High Blood Pressure, or even Kidney Failure.

There are five types of lupus nephritis. Treatment is based on the type of lupus nephritis, which is determined by the biopsy. Since symptoms and severity vary from person to person, treatments are individually tailored to meet a person’s particular circumstances. 

 

Lupus Nephritis Symptoms:

  • The Symptoms OF Lupus Nephritis can be seen as-
  • Discharge OF Blood In Urine
  • High Blood Pressure in the patient
  • Swelling of Hands, Ankles, or Feet
  • Impaired Kidney Function
  • High Level of Creatinine in the blood (Waste Product of the body)

 

Lupus Nephritis Market 

The dynamics of the Lupus Nephritis market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as National Institute of Allergy and Infectious Diseases (NIAID), Teva Branded Pharmaceutical Products R&D, Inc., Novartis Pharmaceuticals, and others during the forecasted period 2019-2032. 

 

Learn more by requesting for sample @ Lupus Nephritis Market Landscape

 

Lupus Nephritis Pipeline Therapies:

  • Secukinumab
  • Zanubrutinib
  • Ravulizumab
  • Anifrolumab
  • Itolizumab
  • Anifrolumab
  •  VIB4920

 

 Lupus Nephritis Pipeline Key Companies:

  • Suzhou Suncadia Biopharmaceuticals Co., Ltd.
  • Teva Branded Pharmaceutical Products R&D, Inc.
  • Novartis Pharmaceuticals
  • Alexion Pharmaceuticals
  • Eledon Pharmaceuticals
  • Resolve Therapeutics
  • Apellis Pharmaceuticals

 

Table of Contents

 1. Report Introduction

2. Executive Summary

3. SWOT analysis

4. Lupus Nephritis Patient Share (%) Overview at a Glance

5. Lupus Nephritis Market Overview at a Glance

6. Lupus Nephritis Disease Background and Overview

7. Lupus Nephritis Epidemiology and Patient Population

8. Country-Specific Patient Population of Lupus Nephritis 

9. Lupus Nephritis Current Treatment and Medical Practices

10. Unmet Needs

11. Lupus Nephritis Emerging Therapies

12. Lupus Nephritis Market Outlook

13. Country-Wise Lupus Nephritis Market Analysis (2018–2030)

14. Market Access and Reimbursement of Therapies

15. Market drivers

16. Market barriers

17. Appendix

18. Lupus Nephritis Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

Click here to read more about Lupus Nephritis Market Outlook 2032

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: +91 9568243403
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com